Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Study Coverage
1.1 Anti-tumor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Anti-tumor Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Cytotoxic Drugs
1.2.3 Non-cytotoxic Drugs
1.3 Market by Application
1.3.1 Global Anti-tumor Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Alkylating Agents
1.3.3 Anti-Metabolism Drugs
1.3.4 Platinum Antineoplastic Agents
1.3.5 Anthracycline Antitumor Drugs
1.3.6 Microtubule Stabilizer
1.3.7 Endocrine Therapy Drugs
1.3.8 Immunotherapy Drugs
1.3.9 Gene Therapy Drugs
1.3.10 Targeted Antineoplastic Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-tumor Drug Market Size Estimates and Forecasts
2.2 Anti-tumor Drug Market Size by Region: 2024 Versus 2031
2.2.1 Global Anti-tumor Drug Revenue by Region: 2020-2025
2.2.2 Global Anti-tumor Drug Revenue Forecast by Region (2026-2031)
2.2.3 Global Anti-tumor Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anti-tumor Drug Revenue by Type (2020-2031)
3.1.2 Global Anti-tumor Drug Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anti-tumor Drug Revenue by Application (2020-2031)
3.2.2 Global Anti-tumor Drug Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Cytotoxic Drugs of Anti-tumor Drug Revenue Market Share by Application
3.3.2 Non-cytotoxic Drugs of Anti-tumor Drug Revenue Market Share by Application
4 Global Anti-tumor Drug by Company
4.1 Global Anti-tumor Drug Revenue by Company (2020-2025)
4.2 Global Anti-tumor Drug Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Anti-tumor Drug Companies around the World: Ranking by Revenue
4.3.2 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Anti-tumor Drug Companies Headquarters & Product Type
4.4.1 Global Anti-tumor Drug Companies Headquarters
4.4.2 Date of International Companies Enter into Anti-tumor Drug Market
4.4.3 Global Anti-tumor Drug Companies Product & Service
4.4.4 Cytotoxic Drugs Revenue Market Share of Anti-tumor Drug by Company
4.4.5 Non-cytotoxic Drugs Revenue Market Share of Anti-tumor Drug by Company
4.5 Global Anti-tumor Drug Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Anti-tumor Drug Products Offered
5.1.4 Roche Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.1.5 Roche Anti-tumor Drug Revenue by Product in 2024
5.1.6 Roche Anti-tumor Drug Revenue by Application in 2024
5.1.7 Roche Anti-tumor Drug Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Novartis
5.2.1 Novartis Corporation Information
5.2.2 Novartis Description, Business Overview
5.2.3 Novartis Anti-tumor Drug Products Offered
5.2.4 Novartis Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.2.5 Novartis Anti-tumor Drug Revenue by Product in 2024
5.2.6 Novartis Anti-tumor Drug Revenue by Application in 2024
5.2.7 Novartis Anti-tumor Drug Revenue by Geographic Area in 2024
5.2.8 Novartis Recent Developments
5.3 Celgene
5.3.1 Celgene Corporation Information
5.3.2 Celgene Description, Business Overview
5.3.3 Celgene Anti-tumor Drug Products Offered
5.3.4 Celgene Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.3.5 Celgene Anti-tumor Drug Revenue by Product in 2024
5.3.6 Celgene Anti-tumor Drug Revenue by Application in 2024
5.3.7 Celgene Anti-tumor Drug Revenue by Geographic Area in 2024
5.3.8 Celgene Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Corporation Information
5.4.2 Bristol-Myers Squibb Description, Business Overview
5.4.3 Bristol-Myers Squibb Anti-tumor Drug Products Offered
5.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.4.5 Bristol-Myers Squibb Anti-tumor Drug Revenue by Product in 2024
5.4.6 Bristol-Myers Squibb Anti-tumor Drug Revenue by Application in 2024
5.4.7 Bristol-Myers Squibb Anti-tumor Drug Revenue by Geographic Area in 2024
5.4.8 Bristol-Myers Squibb Recent Developments
5.5 Amgen
5.5.1 Amgen Corporation Information
5.5.2 Amgen Description, Business Overview
5.5.3 Amgen Anti-tumor Drug Products Offered
5.5.4 Amgen Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.5.5 Amgen Anti-tumor Drug Revenue by Product in 2024
5.5.6 Amgen Anti-tumor Drug Revenue by Application in 2024
5.5.7 Amgen Anti-tumor Drug Revenue by Geographic Area in 2024
5.5.8 Amgen Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Corporation Information
5.6.2 Johnson & Johnson Description, Business Overview
5.6.3 Johnson & Johnson Anti-tumor Drug Products Offered
5.6.4 Johnson & Johnson Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.6.5 Johnson & Johnson Anti-tumor Drug Revenue by Product in 2024
5.6.6 Johnson & Johnson Anti-tumor Drug Revenue by Application in 2024
5.6.7 Johnson & Johnson Anti-tumor Drug Revenue by Geographic Area in 2024
5.6.8 Johnson & Johnson Recent Developments
5.7 Pfizer
5.7.1 Pfizer Corporation Information
5.7.2 Pfizer Description, Business Overview
5.7.3 Pfizer Anti-tumor Drug Products Offered
5.7.4 Pfizer Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.7.5 Pfizer Anti-tumor Drug Revenue by Product in 2024
5.7.6 Pfizer Anti-tumor Drug Revenue by Application in 2024
5.7.7 Pfizer Anti-tumor Drug Revenue by Geographic Area in 2024
5.7.8 Pfizer Recent Developments
5.8 Takeda
5.8.1 Takeda Corporation Information
5.8.2 Takeda Description, Business Overview
5.8.3 Takeda Anti-tumor Drug Products Offered
5.8.4 Takeda Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.8.5 Takeda Anti-tumor Drug Revenue by Product in 2024
5.8.6 Takeda Anti-tumor Drug Revenue by Application in 2024
5.8.7 Takeda Anti-tumor Drug Revenue by Geographic Area in 2024
5.8.8 Takeda Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Corporation Information
5.9.2 Eli Lilly Description, Business Overview
5.9.3 Eli Lilly Anti-tumor Drug Products Offered
5.9.4 Eli Lilly Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.9.5 Eli Lilly Anti-tumor Drug Revenue by Product in 2024
5.9.6 Eli Lilly Anti-tumor Drug Revenue by Application in 2024
5.9.7 Eli Lilly Anti-tumor Drug Revenue by Geographic Area in 2024
5.9.8 Eli Lilly Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Corporation Information
5.10.2 AstraZeneca Description, Business Overview
5.10.3 AstraZeneca Anti-tumor Drug Products Offered
5.10.4 AstraZeneca Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.10.5 AstraZeneca Anti-tumor Drug Revenue by Product in 2024
5.10.6 AstraZeneca Anti-tumor Drug Revenue by Application in 2024
5.10.7 AstraZeneca Anti-tumor Drug Revenue by Geographic Area in 2024
5.10.8 AstraZeneca Recent Developments
5.11 Astellas
5.11.1 Astellas Corporation Information
5.11.2 Astellas Description, Business Overview
5.11.3 Astellas Anti-tumor Drug Products Offered
5.11.4 Astellas Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.11.5 Astellas Anti-tumor Drug Revenue by Product in 2024
5.11.6 Astellas Anti-tumor Drug Revenue by Application in 2024
5.11.7 Astellas Anti-tumor Drug Revenue by Geographic Area in 2024
5.11.8 Astellas Recent Developments
5.12 Merck & Co
5.12.1 Merck & Co Corporation Information
5.12.2 Merck & Co Description, Business Overview
5.12.3 Merck & Co Anti-tumor Drug Products Offered
5.12.4 Merck & Co Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.12.5 Merck & Co Anti-tumor Drug Revenue by Product in 2024
5.12.6 Merck & Co Anti-tumor Drug Revenue by Application in 2024
5.12.7 Merck & Co Anti-tumor Drug Revenue by Geographic Area in 2024
5.12.8 Merck & Co Recent Developments
5.13 Sanofi
5.13.1 Sanofi Corporation Information
5.13.2 Sanofi Description, Business Overview
5.13.3 Sanofi Anti-tumor Drug Products Offered
5.13.4 Sanofi Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.13.5 Sanofi Anti-tumor Drug Revenue by Product in 2024
5.13.6 Sanofi Anti-tumor Drug Revenue by Application in 2024
5.13.7 Sanofi Anti-tumor Drug Revenue by Geographic Area in 2024
5.13.8 Sanofi Recent Developments
5.14 Bayer
5.14.1 Bayer Corporation Information
5.14.2 Bayer Description, Business Overview
5.14.3 Bayer Anti-tumor Drug Products Offered
5.14.4 Bayer Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.14.5 Bayer Anti-tumor Drug Revenue by Product in 2024
5.14.6 Bayer Anti-tumor Drug Revenue by Application in 2024
5.14.7 Bayer Anti-tumor Drug Revenue by Geographic Area in 2024
5.14.8 Bayer Recent Developments
5.15 Biogen Idec
5.15.1 Biogen Idec Corporation Information
5.15.2 Biogen Idec Description, Business Overview
5.15.3 Biogen Idec Anti-tumor Drug Products Offered
5.15.4 Biogen Idec Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.15.5 Biogen Idec Anti-tumor Drug Revenue by Product in 2024
5.15.6 Biogen Idec Anti-tumor Drug Revenue by Application in 2024
5.15.7 Biogen Idec Anti-tumor Drug Revenue by Geographic Area in 2024
5.15.8 Biogen Idec Recent Developments
5.16 Eisai
5.16.1 Eisai Corporation Information
5.16.2 Eisai Description, Business Overview
5.16.3 Eisai Anti-tumor Drug Products Offered
5.16.4 Eisai Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.16.5 Eisai Anti-tumor Drug Revenue by Product in 2024
5.16.6 Eisai Anti-tumor Drug Revenue by Application in 2024
5.16.7 Eisai Anti-tumor Drug Revenue by Geographic Area in 2024
5.16.8 Eisai Recent Developments
5.17 Teva
5.17.1 Teva Corporation Information
5.17.2 Teva Description, Business Overview
5.17.3 Teva Anti-tumor Drug Products Offered
5.17.4 Teva Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.17.5 Teva Anti-tumor Drug Revenue by Product in 2024
5.17.6 Teva Anti-tumor Drug Revenue by Application in 2024
5.17.7 Teva Anti-tumor Drug Revenue by Geographic Area in 2024
5.17.8 Teva Recent Developments
5.18 Otsuka
5.18.1 Otsuka Corporation Information
5.18.2 Otsuka Description, Business Overview
5.18.3 Otsuka Anti-tumor Drug Products Offered
5.18.4 Otsuka Anti-tumor Drug Revenue and Gross Margin (2020-2025)
5.18.5 Otsuka Anti-tumor Drug Revenue by Product in 2024
5.18.6 Otsuka Anti-tumor Drug Revenue by Application in 2024
5.18.7 Otsuka Anti-tumor Drug Revenue by Geographic Area in 2024
5.18.8 Otsuka Recent Developments
6 North America
6.1 North America Anti-tumor Drug Market Size YoY Growth 2020-2031
6.2 North America Anti-tumor Drug Market Facts & Figures by Country (2020-2031)
6.3 North America Anti-tumor Drug Revenue by Type (2020-2025)
6.4 North America Anti-tumor Drug Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anti-tumor Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anti-tumor Drug Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Anti-tumor Drug Revenue by Type (2020-2025)
7.4 Asia-Pacific Anti-tumor Drug Revenue by Application (2020-2025)
8 Europe
8.1 Europe Anti-tumor Drug Market Size YoY Growth 2020-2031
8.2 Europe Anti-tumor Drug Market Facts & Figures by Country (2020-2031)
8.3 Europe Anti-tumor Drug Revenue by Type (2020-2025)
8.4 Europe Anti-tumor Drug Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Anti-tumor Drug Market Size YoY Growth 2020-2031
9.2 Latin America Anti-tumor Drug Market Facts & Figures by Country (2020-2031)
9.3 Latin America Anti-tumor Drug Revenue by Type (2020-2025)
9.4 Latin America Anti-tumor Drug Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anti-tumor Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anti-tumor Drug Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Anti-tumor Drug Revenue by Type (2020-2025)
10.4 Middle East and Africa Anti-tumor Drug Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anti-tumor Drug Supply Chain Analysis
11.2 Anti-tumor Drug Key Raw Materials and Upstream Suppliers
11.3 Anti-tumor Drug Clients Analysis
11.4 Anti-tumor Drug Sales Channel and Sales Model Analysis
11.4.1 Anti-tumor Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anti-tumor Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anti-tumor Drug Distributors
12 Anti-tumor Drug Market Dynamics
12.1 Anti-tumor Drug Industry Trends
12.2 Anti-tumor Drug Market Drivers
12.3 Anti-tumor Drug Market Challenges
12.4 Anti-tumor Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Anti-tumor Drug Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Anti-tumor Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Anti-tumor Drug Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Anti-tumor Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Anti-tumor Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Anti-tumor Drug Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Anti-tumor Drug Revenue by Company (2020-2025) & (US$ Million)
Table 11. Anti-tumor Drug Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Anti-tumor Drug Players by Revenue (US$ Million) in 2024
Table 13. Global Anti-tumor Drug Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Anti-tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2024)
Table 15. Global Anti-tumor Drug Companies Headquarters
Table 16. Date of International Companies Enter into Anti-tumor Drug Market
Table 17. Global Anti-tumor Drug Companies Product & Service
Table 18. Global Anti-tumor Drug Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche Anti-tumor Drug Product
Table 22. Roche Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 24. Roche Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 25. Roche Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Novartis Corporation Information
Table 28. Novartis Description and Business Overview
Table 29. Novartis Anti-tumor Drug Product
Table 30. Novartis Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Novartis Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 32. Novartis Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 33. Novartis Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 34. Novartis Recent Developments
Table 35. Celgene Corporation Information
Table 36. Celgene Description and Business Overview
Table 37. Celgene Anti-tumor Drug Product
Table 38. Celgene Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Celgene Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 40. Celgene Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 41. Celgene Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 42. Celgene Recent Developments
Table 43. Bristol-Myers Squibb Corporation Information
Table 44. Bristol-Myers Squibb Description and Business Overview
Table 45. Bristol-Myers Squibb Anti-tumor Drug Product
Table 46. Bristol-Myers Squibb Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bristol-Myers Squibb Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 48. Bristol-Myers Squibb Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 49. Bristol-Myers Squibb Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 50. Bristol-Myers Squibb Recent Developments
Table 51. Amgen Corporation Information
Table 52. Amgen Description and Business Overview
Table 53. Amgen Anti-tumor Drug Product
Table 54. Amgen Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Amgen Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 56. Amgen Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 57. Amgen Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 58. Amgen Recent Developments
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Anti-tumor Drug Product
Table 62. Johnson & Johnson Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Johnson & Johnson Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 64. Johnson & Johnson Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 65. Johnson & Johnson Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 66. Johnson & Johnson Recent Developments
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer Anti-tumor Drug Product
Table 70. Pfizer Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Pfizer Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 72. Pfizer Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 73. Pfizer Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 74. Pfizer Recent Developments
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Anti-tumor Drug Product
Table 78. Takeda Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Takeda Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 80. Takeda Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 81. Takeda Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 82. Takeda Recent Developments
Table 83. Eli Lilly Corporation Information
Table 84. Eli Lilly Description and Business Overview
Table 85. Eli Lilly Anti-tumor Drug Product
Table 86. Eli Lilly Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Eli Lilly Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 88. Eli Lilly Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 89. Eli Lilly Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 90. Eli Lilly Recent Developments
Table 91. AstraZeneca Corporation Information
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Anti-tumor Drug Product
Table 94. AstraZeneca Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. AstraZeneca Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 96. AstraZeneca Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 97. AstraZeneca Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 98. AstraZeneca Recent Developments
Table 99. Astellas Corporation Information
Table 100. Astellas Description and Business Overview
Table 101. Astellas Anti-tumor Drug Product
Table 102. Astellas Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Astellas Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 104. Astellas Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 105. Astellas Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 106. Astellas Recent Developments
Table 107. Merck & Co Corporation Information
Table 108. Merck & Co Description and Business Overview
Table 109. Merck & Co Anti-tumor Drug Product
Table 110. Merck & Co Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Merck & Co Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 112. Merck & Co Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 113. Merck & Co Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 114. Merck & Co Recent Developments
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Anti-tumor Drug Product
Table 118. Sanofi Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Sanofi Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 120. Sanofi Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 121. Sanofi Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 122. Sanofi Recent Developments
Table 123. Bayer Corporation Information
Table 124. Bayer Description and Business Overview
Table 125. Bayer Anti-tumor Drug Product
Table 126. Bayer Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Bayer Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 128. Bayer Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 129. Bayer Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 130. Bayer Recent Developments
Table 131. Biogen Idec Corporation Information
Table 132. Biogen Idec Description and Business Overview
Table 133. Biogen Idec Anti-tumor Drug Product
Table 134. Biogen Idec Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Biogen Idec Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 136. Biogen Idec Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 137. Biogen Idec Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 138. Biogen Idec Recent Developments
Table 139. Eisai Corporation Information
Table 140. Eisai Description and Business Overview
Table 141. Eisai Anti-tumor Drug Product
Table 142. Eisai Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Eisai Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 144. Eisai Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 145. Eisai Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 146. Eisai Recent Developments
Table 147. Teva Corporation Information
Table 148. Teva Description and Business Overview
Table 149. Teva Anti-tumor Drug Product
Table 150. Teva Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Teva Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 152. Teva Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 153. Teva Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 154. Teva Recent Developments
Table 155. Otsuka Corporation Information
Table 156. Otsuka Description and Business Overview
Table 157. Otsuka Anti-tumor Drug Product
Table 158. Otsuka Anti-tumor Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Otsuka Revenue Proportion of Anti-tumor Drug by Product in 2024
Table 160. Otsuka Revenue Proportion of Anti-tumor Drug by Application in 2024
Table 161. Otsuka Revenue Proportion of Anti-tumor Drug by Geographic Area in 2024
Table 162. Otsuka Recent Developments
Table 163. North America Anti-tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Anti-tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Anti-tumor Drug Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Anti-tumor Drug Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Anti-tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Anti-tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Anti-tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Anti-tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Anti-tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Anti-tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Anti-tumor Drug Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Anti-tumor Drug Revenue by Application (2020-2025) & (US$ Million)
Table 183. Anti-tumor Drug Key Raw Materials, Industry Status and Trend
Table 184. Anti-tumor Drug Key Raw Materials and Upstream Suppliers
Table 185. Anti-tumor Drug Clients Status and Trend
Table 186. Anti-tumor Drug Typical Clients
Table 187. Anti-tumor Drug Distributors
Table 188. Anti-tumor Drug Market Trends
Table 189. Anti-tumor Drug Market Drivers
Table 190. Anti-tumor Drug Market Challenges
Table 191. Anti-tumor Drug Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources


List of Figures
Figure 1. Anti-tumor Drug Product Picture
Figure 2. Global Anti-tumor Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Anti-tumor Drug Revenue Market Share by Type in 2024 & 2031
Figure 4. Cytotoxic Drugs Product Picture
Figure 5. Non-cytotoxic Drugs Product Picture
Figure 6. Global Anti-tumor Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Anti-tumor Drug Revenue Market Share by Application in 2024 & 2031
Figure 8. Alkylating Agents
Figure 9. Anti-Metabolism Drugs
Figure 10. Platinum Antineoplastic Agents
Figure 11. Anthracycline Antitumor Drugs
Figure 12. Microtubule Stabilizer
Figure 13. Endocrine Therapy Drugs
Figure 14. Immunotherapy Drugs
Figure 15. Gene Therapy Drugs
Figure 16. Targeted Antineoplastic Drugs
Figure 17. Anti-tumor Drug Report Years Considered
Figure 18. Global Anti-tumor Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Anti-tumor Drug Market Size (2020-2031) & (US$ Million)
Figure 20. Global Anti-tumor Drug Market Size Market Share by Region: 2024 Versus 2031
Figure 21. Global Anti-tumor Drug Revenue Market Share by Region (2020-2031)
Figure 22. Global Anti-tumor Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 23. Global Anti-tumor Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Cytotoxic Drugs of Anti-tumor Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Non-cytotoxic Drugs of Anti-tumor Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Anti-tumor Drug Revenue Share by Company (2024)
Figure 27. Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Cytotoxic Drugs Revenue Proportion by Company in 2024
Figure 29. Non-cytotoxic Drugs Revenue Proportion by Company in 2024
Figure 30. North America Anti-tumor Drug Revenue 2020-2031 (US$ Million)
Figure 31. North America Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Figure 32. North America Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Anti-tumor Drug Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Anti-tumor Drug Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Figure 37. Europe Anti-tumor Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Anti-tumor Drug Revenue Market Share by Country (2020-2031)
Figure 39. Europe Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Figure 40. Europe Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Anti-tumor Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Anti-tumor Drug Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Anti-tumor Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Anti-tumor Drug Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Figure 49. Anti-tumor Drug Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Anti-tumor Drug Raw Materials by Region in 2024
Figure 51. Anti-tumor Drug Distribution Channels
Figure 52. Global Anti-tumor Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Anti-tumor Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed